Researchers at Tampere University have achieved a major milestone in diagnosing heart diseases. According to their new study ...

ADMA Biologics' growth potential with Asceniv makes it a compelling Buy. Click here to find out why ADMA stock is a Strong ...

The lender posted fourth-quarter results that beat analysts’ expectations and has boosted payouts to shareholders.